Cargando…
Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial
SUMMARY: BACKGROUND: Oral liarozole, a retinoic acid metabolism-blocking agent, may be an alternative to systemic retinoid therapy in patients with lamellar ichthyosis. OBJECTIVE: To demonstrate the efficacy and safety of once-daily oral liarozole in the treatment of moderate/severe lamellar ichthyo...
Autores principales: | Vahlquist, A, Blockhuys, S, Steijlen, P, van Rossem, K, Didona, B, Blanco, D, Traupe, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232915/ https://www.ncbi.nlm.nih.gov/pubmed/24102348 http://dx.doi.org/10.1111/bjd.12626 |
Ejemplares similares
-
Lamellar Ichthyosis with Rickets
por: Ali, Raafia, et al.
Publicado: (2013) -
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis
por: Terrinoni, A, et al.
Publicado: (2012) -
Congenital bilateral ectropion in lamellar ichthyosis
por: Chakraborti, Chandana, et al.
Publicado: (2011) -
Ichthyosis: A Road Model for Skin Research()
por: VAHLQUIST, Anders, et al.
Publicado: (2020) -
Spontaneous subconjunctival abscess in congenital lamellar ichthyosis
por: Bubanale, Shivanand C, et al.
Publicado: (2018)